Lilly's woes highlight the challenges of drug development

The recent announcement that Eli Lilly was halting all clinical testing of its Alzheimer's drug Semagacestat, was a body blow not only to Lilly, but also to the many other companies who are developing their own Alzheimer's medications.

Read More
Suck it and see: Medicine by folklore

Given the incredible time and cost involved in bringing a new drug to market it is interesting that most new drugs are still discovered using the "suck it and see" empirical approach by which our ancestors discovered that the bark of the Willow tree can cure headaches. 

Read More
Welcome to "The Digital Biologist"

Just as the invention of the moving picture gave rise to the cinematographer, the technological advances that are now making it possible to model and simulate complex living systems on a computer are giving rise to a brand new profession - that of The Digital Biologist.

Read More